0512U |
Barbiturates Screen, Urine |
1858U |
Drugs of Abuse (9 Panel) and Alcohol Screen, Urine |
1864U |
Drugs of Abuse Screen (10 Panel), Urine |
1874U |
Drug Screen (9 Panel), Urine |
1876U |
Drug Screen - Expanded, Urine |
2041U |
Flunitrazepam and Metabolites, Urine |
8031U |
Child Drug Exposure Screen, Urine |
8091U |
Drugs of Abuse (11 Panel) and Alcohol Screen, Urine |
8096U |
Drugs of Abuse Screen (11 Panel), Urine |
8101U |
Drugs of Abuse (11 Panel) and Alcohol Screen, Urine |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9329ME |
Benzodiazepines Panel (Qualitative), Meconium |
9341B |
Flunitrazepam and Metabolites Screen, Blood |
9341SP |
Flunitrazepam and Metabolites Screen, Serum/Plasma |
9341TI |
Flunitrazepam and Metabolites Screen, Tissue |
9341U |
Flunitrazepam and Metabolites Screen, Urine |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |